Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease

Recruiting

Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's DiseasePilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease

Sponsor:

Oregon Health and Science University

Code:

NCT06772220

Conditions

Parkinson&Amp;#39;s Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Folic Acid 1 MG

Vitamin B6 25 MG

Vitamin B12

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Oregon Health and Science University on 2025-03-25.